Everything here is written from scientific sources. If you have any doubts, check the original sources.
Ovarian hyperstimulation
This is a reaction to fertility drugs. Around a third of women have a mild form, usually treated at home with pain relief. Severe cases are rare but can be life-threatening1.
Symptoms include a swollen, painful stomach, nausea and vomiting, shortness of breath, faintness and passing little urine. Strong symptoms usually appear the week after egg collection. If you have them, call your clinic straight away1.
To reduce the risk, ESHRE recommends the antagonist protocol for predicted high responders, a GnRH agonist as the final injection where there is risk, and freezing all embryos to eliminate late-onset hyperstimulation2.
Multiple pregnancy
This is the main risk of treatment. At least half of twins are born premature and underweight, and mothers have higher rates of high blood pressure, gestational diabetes, anaemia and haemorrhage1. That is why ESHRE prefers transferring a single embryo3.
Ectopic pregnancy
The embryo implants outside the womb, usually in the fallopian tube, and the pregnancy cannot continue. It causes pain on one side of the lower abdomen, bleeding or brown discharge, and diarrhoea or pain when going to the toilet. Untreated, the tube can rupture1. Women having IVF may be more at risk1.
Other risks
Some studies find a slightly higher risk of pre-eclampsia, gestational diabetes, high blood pressure and post-partum haemorrhage. Birth defects may be linked, but it is unclear whether treatment or underlying infertility is the cause, and any increase is very low1.
Frequently asked questions
What is ovarian hyperstimulation syndrome?
A reaction to fertility drugs. The HFEA says around a third of women have a mild form and that the severe form is rare.
Does IVF increase the risk of ectopic pregnancy?
The HFEA says women having IVF may be more at risk, because an embryo could travel to the fallopian tube during transfer.
Sources
- Human Fertilisation and Embryology Authority (HFEA). Risks of fertility treatment. hfea.gov.uk.
- European Society of Human Reproduction and Embryology (ESHRE). ESHRE guideline: ovarian stimulation for IVF/ICSI. Hum Reprod Open 2020;2020(2):hoaa009.
- European Society of Human Reproduction and Embryology (ESHRE). ESHRE guideline: number of embryos to transfer during IVF/ICSI. Hum Reprod 2024;39(4):647-657.
